Complete blindness after optic neuropathy induced by short-term linezolid treatment in a patient suffering from muscle dystrophy

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 4, 2007, Pages 402-404

  Azamfirei, Leonard ^a,c   Copotoiu, Sanda Maria ^a   Branzaniuc, Klara ^a   Szederjesi, Janos ^a   Copotoiu, Ruxandra ^a   Berteanu, Cristina ^b  

^a UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c NONE   (Romania)

Author keywords

Blindness; Linezolid; Muscle dystrophy; Neuropathy

Indexed keywords

AMOXICILLIN; CARBAMAZEPINE; CORTICOSTEROID; LINEZOLID;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BLINDNESS; BRONCHOPNEUMONIA; CASE REPORT; COMA; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVOKED VISUAL RESPONSE; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUSCULAR DYSTROPHY; OPHTHALMOSCOPY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SHORT COURSE THERAPY; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

ACETAMIDES; ADULT; ANTI-INFECTIVE AGENTS; BLINDNESS; BRONCHOPNEUMONIA; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MUSCULAR DYSTROPHIES; OPTIC NERVE DISEASES; OXAZOLIDINONES;

EID: 34247548711     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1320     Document Type: Article

References (10)

1. Hussar DA. New drugs of 2000. J Am Assoc 2001; 41: 229-272.
2. Rucker JC, Hamilton SR, Bardenstein D, Isada CM, Lee S. Linezolid-associated toxic optic neuropathy. Neurology 2006; 66: 595-598.
3. Carelli V, Ross-Cisneros FN, Sadun AA. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 2004; 23: 53-89.
4. Corallo CE, Paull AE. Linezolid-induced neuropathy. Med J Aust 2002; 177: 332.
5. Davidson S. Reports of ocular adverse reactions. Trans Ophthalmol Soc UK 1973; 93: 495-510.
6. Lee E, Burger S, Shah J, et al. Linezolid-Associated Toxic Optic Neuropathy: A Report of 2 Cases. Clin Infect Dis 2003; 37: 1389-1391.
7. Saijo T, Hayashi K, Yamada H, Wakakura M. Linezolid-induced optic neuropathy. Am J Ophthalmol 2005; 139: 1114-1116.
8. Maidment SL, Ellis JA. Muscular dystrophies, Mated cardiomiopaty, lipodystrophy and neuropaty: the nuclear connection. Expert Rev Mol Med 2002; 2002: 1-21.
9. Benedetti S, Bertini E, Iannaccone S, et al. Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy.J Neurol Neurvsurg Psichiatry 2005; 76:1019-1021.
10. Carelli V, Ross-Cisneros FN, Sadun AA. Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies. Neurochem Int 2002; 40: 573-584.